New devices and technologies for hemodialysis vascular access: a review

TJ Vachharajani, JJ Taliercio, E Anvari - American Journal of Kidney …, 2021 - Elsevier
In the United States, hemodialysis remains the most common treatment modality for kidney
failure, chosen by almost 90% of incident patients. A functioning vascular access is key to …

Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: a systematic review and meta-analysis of randomized …

MT Liao, MK Chen, MY Hsieh, NL Yeh, KL Chien… - PLoS …, 2020 - journals.plos.org
Background Restenosis remains a significant problem in endovascular therapy for
hemodialysis vascular access. Drug-coated balloon (DCB) angioplasty decreases …

[HTML][HTML] Choosing the right treatment for the right lesion, part I: a narrative review of the role of plain balloon angioplasty in dialysis access maintenance

DM DePietro, SO Trerotola - Cardiovascular Diagnosis and …, 2023 - ncbi.nlm.nih.gov
Methods An electronic search was performed on PubMed and EMBASE to identify relevant
articles from 1980 to 2022. The highest available level of evidence regarding stenosis …

Drug‐coated balloon versus plain balloon angioplasty for hemodialysis dysfunction: a meta‐analysis of randomized controlled trials

C Liu, M Wolfers, BZ Awan, I Ali… - Journal of the …, 2021 - Am Heart Assoc
Background Both drug‐coated balloon (DCB) angioplasty and conventional plain balloon
angioplasty (PBA) can be implemented to treat hemodialysis dysfunction. The present study …

[HTML][HTML] Choosing the right treatment for the right lesion, Part II: a narrative review of drug-coated balloon angioplasty and its evolving role in dialysis access …

DM DePietro, SO Trerotola - Cardiovascular Diagnosis and …, 2023 - ncbi.nlm.nih.gov
Methods An electronic search was performed on PubMed and EMBASE to identify relevant
randomized controlled trials (RCTs) comparing DCBs and plain balloon angioplasty from …

[HTML][HTML] Paclitaxel-coated balloon versus plain balloon angioplasty for dysfunctional autogenous radiocephalic arteriovenous fistulas: a prospective randomized …

JW Kim, JH Kim, SS Byun, JM Kang… - Korean Journal of …, 2020 - ncbi.nlm.nih.gov
Objective To report the mid-term results of a single-center randomized controlled trial
comparing drug-coated balloon angioplasty (DBA) and plain balloon angioplasty (PBA) for …

[HTML][HTML] Drug coated balloons for dysfunctional haemodialysis venous access: a patient level meta-analysis of randomised controlled trials

KY Fong, JJ Zhao, E Tan, NL Syn, R Sultana… - European Journal of …, 2021 - Elsevier
Objective To perform an individual patient data level meta-analysis of randomised controlled
trials comparing drug coated balloon angioplasty (DCB) against conventional percutaneous …

[HTML][HTML] Editor's Choice–Paclitaxel Coated Balloon Angioplasty vs. Plain Balloon Angioplasty for Haemodialysis Arteriovenous Access Stenosis: A Systematic Review …

A Han, T Park, HJ Kim, S Min, J Ha, SK Min - European Journal of Vascular …, 2021 - Elsevier
Objective A systematic review and meta-analysis of randomised controlled trials (RCTs) was
performed to determine the effectiveness and safety of drug coated balloon (DCB) …

Drug-coated balloons for the dysfunctional vascular access: an evidence-based road map to treatment and the existing obstacles

P Kitrou, K Katsanos, GA Georgopoulou… - Seminars in …, 2022 - thieme-connect.com
An underlying stenosis within the venous limb of a hemodialysis access circuit is the main
etiology for graft and fistula dysfunction as well as other symptoms such as arm, breast, and …

A Prospective Multicenter Randomized Controlled Trial for Comparing Drug-Coated and Conventional Balloon Angioplasty in Venous Anastomotic Stenosis of …

DE Goo, YJ Kim, SW Park, HJ Cheon, YD Won… - CardioVascular and …, 2024 - Springer
Purpose To evaluate the efficacy and safety of drug-coated balloon angioplasty compared to
conventional balloon angioplasty in the treatment of dysfunctional arteriovenous grafts …